Short answer: Citicoline (CDP-choline) is the body’s own intermediate for building phosphatidylcholine — the phospholipid that brain-cell membranes are made of. It is so central to neurology that in Japan and parts of Europe it has long been handled as a prescription medicine, not a shelf supplement. Swallowed citicoline is very well absorbed — it is split in the gut into choline and cytidine, both of which reach the brain and are reassembled there — so, unlike curcumin or fisetin, the argument for a compounding pharmacy is not liposomal delivery. The argument is precision: trial-anchored dosing (500 mg/day in the memory RCT; 500–1,000 mg/day in the glaucoma studies), a clean excipient-free capsule or a measured oral liquid for older adults who struggle with fixed-strength retail formats, and a doctor’s review of what it is being combined with. The evidence itself is genuinely mixed — one good RCT on episodic memory, a European regulator that remains unconvinced, encouraging adjunct data in glaucoma, and a firmly negative verdict in acute stroke — which is exactly why it belongs behind a prescription and a practitioner’s judgement, compounded under Good Compounding Practice (GCP).
Clinically reviewed by the Lynnity compounding team — pharmacists registered with the Pharmacy Board of Malaysia. This article is practitioner education for clinics in Kuala Lumpur, the Klang Valley and Singapore; it is not medical advice and does not replace an individual prescription.
What citicoline is — and why neurologists take it seriously
Citicoline is the international non-proprietary name for cytidine-5′-diphosphocholine (CDP-choline). It is not an exotic botanical: it is a molecule every human cell already makes, the rate-limiting intermediate of the Kennedy pathway that assembles phosphatidylcholine, the dominant phospholipid of neuronal membranes. Supplying it exogenously is, in effect, handing the brain a pre-paid building block for membrane repair, and supplying choline this way also supports the synthesis of acetylcholine, the neurotransmitter most closely tied to attention and memory.
That pedigree explains its unusual regulatory history. Citicoline has been prescribed for decades in Japan and in several European countries under drug licences, while in the United States and much of Asia it circulates as a food-supplement ingredient. In Malaysia it sits in a familiar gap for our readers: it is not a routine item on retail pharmacy shelves, and patients who ask about it have usually read about it in longevity or “nootropic” media. For a clinic, the practical route to a defined, quality-controlled dose is a doctor’s prescription filled by a licensed compounding pharmacy.
The pharmacology: well absorbed, cleverly reassembled
Oral citicoline is broken apart in the intestinal wall and liver into its two halves — choline and cytidine (which in humans circulates largely as uridine). Pharmacokinetic work consistently describes near-complete oral absorption, with the two components crossing the blood–brain barrier separately and being re-synthesised into CDP-choline and onward into phosphatidylcholine inside brain cells. Studies suggest very little of the parent molecule needs to survive intact for the dose to do its work — the brain rebuilds it on site.
This matters for an honest compounding conversation. With resveratrol, curcumin or fisetin, the pharmacy’s first contribution is getting a poorly-absorbed molecule into the bloodstream, often liposomally. Citicoline does not need that rescue. What it needs is the same discipline any borderline-drug nutrient needs: the studied dose rather than a guess, a formulation the specific patient can actually take, and a prescriber who knows what else is on the medication list.
What the human evidence actually shows — honestly
Memory in older adults: one good trial, and a sceptical regulator
The strongest recent study is a randomised, double-blind, placebo-controlled trial by Nakazaki and colleagues (Journal of Nutrition, 2021): 100 healthy adults aged 50–85 with age-associated memory impairment took citicoline 500 mg/day or placebo for 12 weeks. The citicoline group improved on episodic memory measures compared with placebo; short-term and working memory were unchanged. That is a real, placebo-controlled signal — but it is one trial, in one population, on one memory domain.
The counterweight belongs in the same paragraph: in 2024 the European Food Safety Authority reviewed the memory-support claim for citicoline and concluded a cause-and-effect relationship had not been established, noting that other trials at 1 g/day did not reproduce the effect. Practitioners should present citicoline to patients in exactly those terms — a promising, well-tolerated nutrient with mixed evidence — not as a proven memory treatment.
Glaucoma: an adjunct with growing trial support
Ophthalmology has quietly become citicoline’s most active research field. Multiple randomised studies in open-angle glaucoma patients whose eye pressure is already controlled — including a 12-month double-blind trial of a 500 mg/day oral solution and crossover trials of citicoline-based combinations — report improvements in retinal ganglion-cell electrical function (PERG/VEP) and, in an international placebo-controlled crossover trial, in vision-related quality of life. The consistent framing across these papers: citicoline is studied as an add-on to pressure-lowering therapy, never a replacement for it.
Stroke: a clear negative worth knowing
Honesty also means the failures. The large international ICTUS trial (2012) tested citicoline in acute ischaemic stroke and found no overall benefit. Whatever a patient may have read online, citicoline is not a stroke treatment, and no compounded preparation changes that.
Where a compounding pharmacy genuinely adds value
Because absorption is not the problem, the pharmacy’s contribution is everything around the molecule:
- Trial-anchored strength. The memory RCT used 500 mg/day; glaucoma studies used 500–1,000 mg/day. Commercial imports come in fixed strengths that rarely map onto what the prescriber actually wants — a compounded capsule can be made at exactly the studied dose, or titrated.
- Formats real patients can take. The glaucoma trials themselves used an oral solution — a natural fit for the older adults this molecule is most discussed for, many of whom manage long medication lists and swallowing difficulty. Lynnity can prepare a measured oral liquid, a flavoured liquid, or a plain capsule; a sublingual liquid held under the tongue is an option where a doctor prefers it. (Unlike fixed-strength retail tablets, the strength and format follow the prescription.)
- Excipient-free by design. A compounded capsule can be limited to citicoline and a minimal carrier — relevant for patients with sensitivities to the coatings, colourants and bulking agents in mass-produced formats.
- One regimen, one review. Patients interested in citicoline are often already taking other cognitive or eye-health actives. A prescriber-led compounded regimen puts the combination through one medication review instead of an accumulating shelf of self-selected bottles.
Safety, interactions and the prescription gate
Across trials citicoline has been well tolerated at the doses above, with side effects (when reported) mostly limited to mild digestive upset or headache. It is not a molecule with dramatic interaction warnings, but a doctor’s review still matters: cholinergic load alongside other pro-cholinergic medicines, the patient’s cognitive work-up (new memory complaints deserve assessment, not a supplement), and the glaucoma context, where citicoline must never displace prescribed pressure-lowering drops.
As with every preparation Lynnity dispenses — supplements included — compounded citicoline requires a prescription from a registered medical practitioner. Compounded preparations are made for a named patient under Good Compounding Practice (GCP) and are not carried as retail stock.
For clinics in KL, the Klang Valley and Singapore
If your patients are asking about citicoline — memory clinics, ophthalmology practices co-managing stable glaucoma, geriatric and general practices fielding “brain supplement” questions — Lynnity can support you with a practitioner conversation on formulation and dosing, and prepare prescription-based capsules or oral liquids at the strength you specify. Referral and prescription workflows for Malaysian and Singaporean practitioners are described on our site, and our pharmacists are happy to walk your team through the evidence summarised above.
Frequently asked questions
Is citicoline available in pharmacies in Malaysia?
It is not a routine retail item in Malaysia. In Japan and parts of Europe citicoline has long been a prescription medicine. In Malaysia, the practical route to a defined, quality-controlled dose is a doctor’s prescription filled by a licensed compounding pharmacy such as Lynnity.
Does citicoline improve memory?
The evidence is mixed. One randomised placebo-controlled trial in older adults (500 mg/day, 12 weeks) showed improved episodic memory, but the European Food Safety Authority concluded in 2024 that the overall evidence does not yet establish the claim. It should be framed as promising, not proven.
Can citicoline treat glaucoma or replace my eye drops?
No. Trials study citicoline only as an add-on in patients whose eye pressure is already controlled, where it has shown encouraging effects on retinal nerve function and vision-related quality of life. It never replaces prescribed glaucoma therapy.
Does citicoline need a liposomal formulation?
No — and an honest pharmacy should say so. Citicoline is very well absorbed orally. The value of compounding lies in precise, trial-anchored dosing, excipient-free capsules, and measured oral liquids, not in bioavailability rescue.
What forms can Lynnity compound citicoline in?
On prescription: a capsule, a measured oral liquid (plain or flavoured), or a sublingual liquid held under the tongue, at the strength the prescriber specifies.
Do I need a prescription for compounded citicoline?
Yes. All Lynnity preparations, including supplements, are compounded for a named patient against a prescription from a registered medical practitioner, under Good Compounding Practice (GCP).
Lynnity Compounding Pharmacy, Kuala Lumpur · Prescription-only · Good Compounding Practice (GCP). This article is educational material for healthcare practitioners and does not constitute medical advice, a claim of treatment or cure, or an offer of supply without prescription.